The survey effects of botulinum toxin A on quality of life in women with overactive bladder and urge urinary incontinence in patient in Imam Reza Hospital in Kermanshah in 2017

The survey effects of botulinum toxin A on quality of life in women with overactive bladder and urge urinary incontinence

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100301003461N10

Enrollment

Registered

2018-07-06

Start date

2017-07-19

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder syndrome. other specified disorders of bladder

Interventions

The patient in the operating room will be undergoing cystoscopy by a urologist and assistant women's participation, and toxin botulinum A at 0.5 ccs will be injected with a needle in 20 points of the

Eligibility

Sex/Gender

Female

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: Aged over 50 years and Menopause Married Having overactive bladder symptoms Those who have not responded to anticholinergicmedications Have side effects Have a BMI of between 20-30 Anticholinergic drugs should not be used for 7 days prior of examination and during treatment Patients should have a residual urine of 100 cc or Less Mentally and physically capable of intermittent catheterization urge urinary incontinence

Exclusion criteria

Exclusion criteria: Diabetes history Hypertension history Neurological Diseases such as multiple sclerosis, Myasthenia Gravis and Stroke, Alzheimer's disease, Psychiatric Disorders, Major Uterine Masses History of Chronic Urinary Tract Infections

Design outcomes

Primary

Measure	Time frame
Quality of life in women with overactive bladder and urge urinary incontinence. Timepoint: Before Treatment, One Months After treatment,Six Months After Treatment. Method of measurement: I-QOL Questionnaire to Measure The Effects of Urge Urinary Incontinence on Quality of Life.;Urinary incontinence. Timepoint: Before Treatment, One Months After treatment,Six Months After Treatment. Method of measurement: Ask the patient.	—

Measure

Time frame

Quality of life in women with overactive bladder and urge urinary incontinence. Timepoint: Before Treatment, One Months After treatment,Six Months After Treatment. Method of measurement: I-QOL Questionnaire to Measure The Effects of Urge Urinary Incontinence on Quality of Life.;Urinary incontinence. Timepoint: Before Treatment, One Months After treatment,Six Months After Treatment. Method of measurement: Ask the patient.

—

Secondary

Measure	Time frame
Urinary Tract Infection. Timepoint: Before treatment, one months after treatment,six months after treatment. Method of measurement: Experiment results.;Hematuria. Timepoint: Before treatment, one month after treatment, six months after treatment. Method of measurement: Observation and experiment results.;Dysuria. Timepoint: Before treatment, one month after treatment, six months after treatment. Method of measurement: Ask the Patient.	—

Measure

Time frame

Urinary Tract Infection. Timepoint: Before treatment, one months after treatment,six months after treatment. Method of measurement: Experiment results.;Hematuria. Timepoint: Before treatment, one month after treatment, six months after treatment. Method of measurement: Observation and experiment results.;Dysuria. Timepoint: Before treatment, one month after treatment, six months after treatment. Method of measurement: Ask the Patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoumeh Bayati

Kermanshah university of Medical Sciences

bayati.masoumeh1985@gmail.com+98 83 3836 0014

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026